Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 8, 2009, Pages 1005-1013

  Ruckhäberle, Eugen ^a   Karn, Thomas ^a   Rody, Achim ^a   Hanker, Lars ^a   Gätje, Regine ^a   Metzler, Dirk ^a   Holtrich, Uwe ^a   Kaufmann, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Breast cancer; CERK; Microarray; Sphingolipid; ST8SIA1; UGT8

Indexed keywords

CERAMIDE KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GALACTOSYLCERAMIDE; GANGLIOSIDE GD3; SPHINGOLIPID;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GRADING; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GANGLIOSIDE GALACTOSYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; RECEPTOR, ERBB-2; SIALYLTRANSFERASES; TISSUE ARRAY ANALYSIS;

EID: 68149091582     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0536-6     Document Type: Article

References (56)

1. A Ahr T Karn C Solbach T Seiter K Strebhardt U Holtrich M Kaufmann 2002 Identification of high risk breast-cancer patients by gene expression profiling Lancet 359 131 132 10.1016/S0140-6736(02)07337-3
2. G Alexe GS Dalgin D Scanfeld P Tamayo JP Mesirov C DeLisi L Harris N Barnard M Martel AJ Levine S Ganesan G Bhanot 2007 High expression of lymphocyte-associated genes in node-negative HER2 + breast cancers correlates with lower recurrence rates Cancer Res 67 10669 10676 10.1158/0008-5472.CAN-07- 0539
3. H Bonnefoi A Potti M Delorenzi L Mauriac M Campone M Tubiana-Hulin T Petit P Rouanet J Jassem E Blot V Becette P Farmer S André CR Acharya S Mukherjee D Cameron J Bergh JR Nevins RD Iggo 2007 Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial Lancet Oncol 8 1071 1078 10.1016/S1470-2045(07)70345-5
4. Dahm F, Bielawska A, Nocito A, Georgiev P, Szulc ZM, Bielawski J, Jochum W, Dindo D, Hannun YA, Clavien PA (2008) Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice. Br J Cancer 98(1):98-105
5. C Desmedt F Piette S Loi Y Wang F Lallemand B Haibe-Kains G Viale M Delorenzi Y Zhang MS d'Assignies J Bergh R Lidereau P Ellis AL Harris JG Klijn JA Foekens F Cardoso MJ Piccart M Buyse C Sotiriou 2007 TRANSBIG Consortium. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 13 3207 3214 (Pubitemid 46944903)
6. H Devalapally Z Duan MV Seiden MM Amiji 2007 Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer Int J Cancer 121 8 1830 1838 10.1002/ijc.22886
7. JA Foekens D Atkins Y Zhang FC Sweep N Harbeck A Paradiso T Cufer AM Sieuwerts D Talantov PN Span VC Tjan-Heijnen AF Zito K Specht H Hoefler R Golouh F Schittulli M Schmitt LV Beex JG Klijn Y Wang 2006 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer J Clin Oncol 24 1665 1671 10.1200/JCO.2005.03.9115
8. Fujii S, Shimizu K, Hemmi H, Fukui M, Bonito AJ, Chen G, Franck RW, Tsuji M, Steinman RM (2006) Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc Natl Acad Sci USA 103(30):11252-11257 (Epub 2006 Jul 14) (Pubitemid 44156505)
9. G Giaccone CJA Punt Y Ando 2002 A phase I study of the natural killer T-cell ligand a-galactosylceramide (KRN7000) in patients with solid tumors Clin Cancer Res 8 3702 3709 (Pubitemid 35424759)
10. DI Godfrey M Kronenberg 2004 Going both ways: immune regulation via CD1d-dependent NKT cells J Clin Invest 114 1379 1388 (Pubitemid 40385565)
11. A Gomez-Munoz 2006 Ceramide 1-phosphate/ceramide, a switch between life and death Biochim Biophys Acta 1758 2049 2056 10.1016/j.bbamem.2006.05.011
12. A Gomez-Munoz PA Duffy A Martin L O'Brien H-S Byun R Bittman DN Brindley 1995 Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides Mol Pharmacol 47 883 889
13. A Gomez-Munoz JY Kong B Salh UP Steinbrecher 2004 Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages J Lipid Res 45 99 105 10.1194/jlr.M300158-JLR200
14. Y Gong K Yan F Lin K Anderson C Sotiriou F Andre FA Holmes V Valero D Booser JE Pippen Jr S Vukelja H Gomez J Mejia LJ Barajas KR Hess N Sneige GN Hortobagyi L Pusztai WF Symmans 2007 Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study Lancet Oncol 8 203 211 10.1016/S1470-2045(07)70042-6
15. V Gouaze YY Liu CS Prickett JY Yu AE Giuliano MC Cabot 2005 Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs Cancer Res 65 9 3861 3867 10.1158/0008-5472.CAN-04-2329
16. V Gouaze-Andersson MC Cabot 2006 Glycosphingolipids and drug resistance Biochim Biophys Acta 1758 2096 2103 10.1016/j.bbamem.2006.08.012
17. V Gouaze-Andersson JY Yu AJ Kreitenberg A Bielawska AE Giuliano MC Cabot 2007 Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells Biochim Biophys Acta 1771 12 1407 1417
18. YA Hannun LM Obeid 2008 Principles of bioactive lipid signaling: lessons from sphingolipids Nat Rev Mol Cell Biol 9 139 150 10.1038/nrm2329
19. T Hattori S Kokura T Okuda T Okayama T Takagi O Handa Y Naito N Yoshida T Yoshikawa 2007 Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer Int J Hyperthermia 23 7 591 598 10.1080/02656730701708328
20. Y Hayakawa K Takeda H Yagita MJ Smyth L Van Kaer K Okumura I Saiki 2002 IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide Blood 100 5 1728 1733 (Pubitemid 34925151)
21. V Hinkovska-Galcheva LA Boxer A Kindzelskii M Hiraoka A Abe S Goparju S Spiegel HR Petty JA Shayman 2005 Ceramide 1-phosphate, a mediator of phagocytosis J Biol Chem 280 26612 26621 10.1074/jbc.M501359200
22. A Huwiler T Kolter J Pfeilschifter K Sandhoff 2000 Physiology and pathophysiology of sphingolipid metabolism and signaling Biochim Biophys Acta 1485 2-3 63 99 (Pubitemid 30314727)
23. A Huwiler J Pfeilschifter 2006 Altering the sphingosine-1-phosphate/ ceramide balance: a promising approach for tumor therapy Curr Pharm Des 12 35 4625 4635 10.2174/138161206779010422
24. RA Irizarry BM Bolstad F Collin LM Cope B Hobbs TP Speed 2003 Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 e15 10.1093/nar/gng015
25. A Ishikawa S Motohashi E Ishikawa 2005 A phase I study of a-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer Clin Cancer Res 11 1910 1917 10.1158/1078-0432.CCR-04-1453
26. K Ko K Furukawa T Takahashi T Urano Y Sanai M Nagino Y Nimura K Furukawa 2006 Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers Oncogene 25 52 6924 6935 10.1038/sj.onc.1209683
27. S Lahiri AH Futerman 2007 The metabolism and function of sphingolipids and glycosphingolipids Cell Mol Life Sci 64 17 2270 2284 10.1007/s00018-007- 7076-0
28. NF Lamour CE Chalfant 2008 Ceramide kinase and the ceramide-1-phosphate/ cPLA2alpha interaction as a therapeutic target Curr Drug Targets 9 8 674 682 10.2174/138945008785132349
29. C Li WH Wong 2001 Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection Proc Natl Acad Sci USA 98 1 31 36 10.1073/pnas.011404098
30. YY Liu JY Yu D Yin GA Patwardhan V Gupta Y Hirabayashi WM Holleran AE Giuliano SM Jazwinski V Gouaze-Andersson DP Consoli MC Cabot 2008 A role for ceramide in driving cancer cell resistance to doxorubicin FASEB J 22 7 2541 2551 10.1096/fj.07-092981
31. K Liu J Idoyaga A Charalambous S Fujii A Bonito J Mordoh R Wainstok XF Bai Y Liu RMJ Steinman 2005 Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells Exp Med 202 1507 1516 10.1084/jem.20050956
32. S Loi B Haibe-Kains C Desmedt F Lallemand AM Tutt C Gillet P Ellis A Harris J Bergh JA Foekens JG Klijn D Larsimont M Buyse G Bontempi M Delorenzi MJ Piccart C Sotiriou 2007 Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade J Clin Oncol 25 1239 1246 10.1200/JCO.2006.07.1522
33. LD Miller J Smeds J George VB Vega L Vergara A Ploner Y Pawitan P Hall S Klaar ET Liu J Bergh 2005 An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 102 13550 13555 10.1073/pnas.0506230102
34. AJ Minn GP Gupta D Padua P Bos DX Nguyen D Nuyten B Kreike Y Zhang Y Wang H Ishwaran JA Foekens M van de Vijver J Massagué 2007 Lung metastasis genes couple breast tumor size and metastatic spread Proc Natl Acad Sci USA 104 6740 6745 10.1073/pnas.0701138104
35. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri A Viale AB Olshen WL Gerald J Massagué 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518 524 10.1038/nature03799
36. Mitra P, Maceyka M, Payne SG, Lamour N, Milstien S, Chalfant CE, Spiegel S (2007) Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. FEBS Lett 581(4):735-740 (Epub 2007 Jan 25) (Pubitemid 46217927)
37. S Mitsutake TJ Kim Y Inagaki M Kato T Yamashita Y Igarashi 2004 Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells J Biol Chem 279 17570 17577 10.1074/jbc.M312885200
38. DE Modrak DV Gold DM Goldenberg 2006 Sphingolipid targets in cancer therapy Mol Cancer Ther 5 2 200 208 10.1158/1535-7163.MCT-05-0420
39. S Motohashi A Ishikawa E Ishikawa 2006 A phase I study of in vitro expanded natural killer T cells inpatients with advanced and recurrent non-small cell lung cancer Clin Cancer Res 12 6079 6086 10.1158/1078-0432.CCR-06-0114
40. JE Park DY Wu M Prendes SX Lu G Ragupathi N Schrantz PB Chapman 2008 Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand Immunology 123 1 145 155 10.1111/j.1365-2567.2007.02760.x
41. Y Pawitan J Bjohle L Amler AL Borg S Egyhazi P Hall X Han L Holmberg F Huang S Klaar ET Liu L Miller H Nordgren A Ploner K Sandelin PM Shaw J Smeds L Skoog S Wedren J Bergh 2005 Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Res 7 R953 R964 10.1186/bcr1325
42. A Rody U Holtrich R Gaetje M Gehrmann K Engels G von Minckwitz S Loibl R Diallo-Danebrock E Ruckhäberle D Metzler A Ahr C Solbach T Karn M Kaufmann 2007 Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1 Clin Cancer Res 13 1115 1122 10.1158/1078-0432.CCR-06-2433
43. E Ruckhäberle T Karn L Hanker R Gätje D Metzler U Holtrich M Kaufmann A Rody 2008 Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer J Cancer Res Clin Oncol 135 1 81 90
44. E Ruckhäberle A Rody K Engels R Gaetje G von Minckwitz S Schiffmann S Grosch G Geisslinger U Holtrich T Karn M Kaufmann 2007 Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer Breast Cancer Res Treat 112 1 41 52
45. S Saxena M Banerjee RK Shirumalla A Ray 2008 Ceramide kinase: a potential anti-inflammatory target? Curr Opin Investig Drugs 9 5 455 462 (Pubitemid 351677898)
46. D Shida K Takabe D Kapitonov S Milstien S Spiegel 2008 Targeting SphK1 as a new strategy against cancer Curr Drug Targets 9 8 662 673 10.2174/138945008785132402
47. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds H Nordgren P Farmer V Praz B Haibe-Kains C Desmedt D Larsimont F Cardoso H Peterse D Nuyten M Buyse MJ Van de Vijver J Bergh M Piccart M Delorenzi 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 262 272 (Pubitemid 43264710)
48. AP Struckhoff R Bittman ME Burow S Elliott T Hammond Y Tang BS Beckman 2004 Novel ceramide analogs as potential chemotherapeutic agents in breast cancer J Pharmacol Exp Ther 309 2 523 532 (Pubitemid 38542603)
49. TA Taha TD Mullen LM Obeid 2006 A house divided: ceramidesphingosine, and sphingosine-1-phosphate in programmed cell death Biochim Biophys Acta 1758 2027 2036 10.1016/j.bbamem.2006.10.018
50. K Takabe SW Paugh S Milstien S Spiegel 2008 "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets Pharmacol Rev 60 2 181 195 10.1124/pr.107.07113
51. MW Teng JA Westwood PK Darcy J Sharkey M Tsuji RW Franck SA Porcelli GS Besra K Takeda H Yagita MH Kershaw MJ Smyth 2007 Combined natural killer T-cell based immunotherapy eradicates established tumors in mice Cancer Res 67 15 7495 7504 10.1158/0008-5472.CAN-07-0941
52. The International Genomics Consortium (IGC) The expO project (Expression Project For Oncology) http://www.intgen.org/
53. T Uchida S Horiguchi Y Tanaka H Yamamoto N Kunii S Motohashi M Taniguchi T Nakayama Y Okamoto 2008 Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer Cancer Immunol Immunother 57 3 337 345 10.1007/s00262-007-0373-5
54. B Visentin JA Vekich BJ Sibbald AL Cavalli KM Moreno RG Matteo WA Garland Y Lu S Yu HS Hall V Kundra GB Mills RA Sabbadini 2006 Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 9 3 225 238 10.1016/j.ccr.2006.02.023
55. Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang D Talantov M Timmermans ME Meijer-van Gelder J Yu T Jatkoe EM Berns D Atkins JA Foekens 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 671 679 (Pubitemid 40260888)
56. DY Wu NH Segal S Sidobre M Kronenberg PB Chapman 2003 Cross-presentation of disialoganglioside GD3 to natural killer T cells J Exp Med 198 173 181 10.1084/jem.20030446